Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
Clinical trial NCT06341855 · UNKNOWN
Trial details
- NCT number
- NCT06341855
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2026-01-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.